Article
Lower Platelet Aggregation Is a Risk Factor for Dual Antiplatelet Therapy-Associated Bleeding: A Preliminary Retrospective Study with Genotype Analysis.
Medical science monitor : international medical journal of experimental and clinical research - 16 Jun 2020
Yuan Dongdong, Shi Xiangfen, Guo Liping, Wang Gaobiao, Zhao Yujie, Yang Yuling, Zhang Hanjuan, Huang Qiong, Yuan Yiqiang
Abstract excerpt
BACKGROUND The purpose of this study was to investigate factors influencing bleeding in patients with acute coronary syndrome (ACS) who are on aspirin and ticagrelor as dual antiplatelet therapy. MATERIAL AND METHODS This retrospective case-control study included 50 patients with ACS (25 with reported bleeding events and 25 without) on aspirin and ticagrelor. Adenosine diphosphate (ADP)- and arachidonic acid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
